Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Caignard

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Blood|April 26, 2000
Killer inhibitory receptor (CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomasN Guerra, M Guillard, E Angevin, et al.
Cancer Research|April 20, 2001
Tumor cells regulate the lytic activity of tumor-specific cytotoxic t lymphocytes by modulating the inhibitory natural killer receptor functionA Gati, N Guerra, J Giron-Michel, et al.
European Journal of Immunology|April 1, 1991
Molecular characterization of human T cell receptor alpha chains including a V delta 1-encoded variable segmentC Miossec, A Caignard, L Ferradini, et al.
European Cytokine Network|June 9, 2005
The sensitivity of renal cell carcinoma cells to interferon alpha correlates with p53-induction and involves BaxS Wittnebel, A Jalil, J Thiery, et al.
International Journal of Cancer|July 9, 1993
Influence of interleukin-2 administration on the expression of T-cell receptor V gene segments in patients with renal-cell carcinomaF Farace, E Angevin, B Escudier, et al.
International Immunology|August 1, 1997
TCR analysis reveals significant repertoire selection during in vitro lymphocyte cultureP Y Dietrich, P R Walker, V Schnuriger, et al.
Oncogene|January 25, 2011
Mutations of the von Hippel-Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinomaA Perier, G Fregni, S Wittnebel, et al.
Tissue Antigens|October 1, 1996
Inhibition of the human allogeneic mixed lymphocyte response by cyclosporin A: relationship with the IL-12 pathwayB Bonnotte, C Pardoux, J H Bourhis, et al.
International Journal of Cancer|April 22, 1993
Analysis of T-cell-receptor variable gene segment usage in peripheral-blood lymphocytes of advanced cancer patientsE Angevin, F Farace, C Genevée, et al.
Cancer Research|September 18, 2001
Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinomaE C Ibrahim, N Guerra, M J Lacombe, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Blood|April 26, 2000
Killer inhibitory receptor (CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomasN Guerra, M Guillard, E Angevin, et al.
Cancer Research|April 20, 2001
Tumor cells regulate the lytic activity of tumor-specific cytotoxic t lymphocytes by modulating the inhibitory natural killer receptor functionA Gati, N Guerra, J Giron-Michel, et al.
European Journal of Immunology|April 1, 1991
Molecular characterization of human T cell receptor alpha chains including a V delta 1-encoded variable segmentC Miossec, A Caignard, L Ferradini, et al.
European Cytokine Network|June 9, 2005
The sensitivity of renal cell carcinoma cells to interferon alpha correlates with p53-induction and involves BaxS Wittnebel, A Jalil, J Thiery, et al.
International Journal of Cancer|July 9, 1993
Influence of interleukin-2 administration on the expression of T-cell receptor V gene segments in patients with renal-cell carcinomaF Farace, E Angevin, B Escudier, et al.
International Immunology|August 1, 1997
TCR analysis reveals significant repertoire selection during in vitro lymphocyte cultureP Y Dietrich, P R Walker, V Schnuriger, et al.
Oncogene|January 25, 2011
Mutations of the von Hippel-Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinomaA Perier, G Fregni, S Wittnebel, et al.
Tissue Antigens|October 1, 1996
Inhibition of the human allogeneic mixed lymphocyte response by cyclosporin A: relationship with the IL-12 pathwayB Bonnotte, C Pardoux, J H Bourhis, et al.
International Journal of Cancer|April 22, 1993
Analysis of T-cell-receptor variable gene segment usage in peripheral-blood lymphocytes of advanced cancer patientsE Angevin, F Farace, C Genevée, et al.
Cancer Research|September 18, 2001
Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinomaE C Ibrahim, N Guerra, M J Lacombe, et al.
Pageof 6